Evidence map›Paper›PMID 32197522›Full record

ArticleMetabolites2020

16HBE Cell Lipid Mediator Responses to Mono and Co-Infections with Respiratory Pathogens.

Daniel Schultz, Surabhi Surabhi, Nicolas Stelling, Michael Rothe, KoInfekt Study Group, Karen Methling, Sven Hammerschmidt, Nikolai Siemens, Michael Lalk

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. The influence ofFrontiers in pharmacology · 2023
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Daniel SchultzInstitute of Biochemistry, University of Greifswald, 17487 Greifswald, Germany.
Surabhi SurabhiDepartment of Molecular Genetics and Infection Biology, University of Greifswald, Germany.
Nicolas StellingDepartment of Molecular Genetics and Infection Biology, University of Greifswald, Germany.
Michael RotheLipidomix, 13125 Berlin, Germany.
KoInfekt Study Group
Karen MethlingInstitute of Biochemistry, University of Greifswald, 17487 Greifswald, Germany.
Sven HammerschmidtDepartment of Molecular Genetics and Infection Biology, University of Greifswald, Germany.
Nikolai SiemensDepartment of Molecular Genetics and Infection Biology, University of Greifswald, Germany.
Michael LalkInstitute of Biochemistry, University of Greifswald, 17487 Greifswald, Germany.
Universität Greifswald · DELipidomix (Germany) · DE

Funding

Deutsche Forschungsgemeinschaft GRK1870Mecklenburg-Pomerania Excellence Initiative (Germany) and European Social Fund (ESF) ESF_14-BM-A55-00xx_16
6 · The paper itself

Abstract

Respiratory tract infections are a global health problem. The main causative agents of these infections are influenza A virus (IAV),

Indexed as

co-infectioneicosanoidsinfluenza A viruslipid mediatorsoxylipinsrespiratory tract infectionS. aureusS. pneumoniae

Identifiers

PMID32197522
PMCPMC7142531
OpenAlexW3012326482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.